Nitric oxide and potassium channels mediate GM1 ganglioside-induced vasorelaxation

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 380, Issue 6, 2009, Pages 487-495

  Furian, Ana Flávia ^a,b   Rattmann, Yanna Dantas ^c   Oliveira, Mauro Schneider ^a,b   Royes, Luiz Fernando Freire ^a   Marques, Maria Consuelo Andrade ^c   Santos, Adair Roberto Soares ^d   Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Endothelium; Guanylate cyclase; Mesenteric artery; Nitric oxide; Potassium channel

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; APAMIN; CHARYBDOTOXIN; GANGLIOSIDE GM1; GLIBENCLAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHENYLEPHRINE; POTASSIUM CHANNEL; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM CONDUCTANCE; CONTROLLED STUDY; ENDOTHELIUM; MALE; MESENTERIC ARTERY; NONHUMAN; POTASSIUM CONDUCTANCE; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; VASODILATATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; G(M1) GANGLIOSIDE; GUANYLATE CYCLASE; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; POTASSIUM CHANNELS; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 71349083306     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-009-0469-x     Document Type: Article

References (54)

1. A Alioua Y Tanaka M Wallner F Hofmann P Ruth P Meera L Toro 1998 The large conductance, voltage-dependent, and calcium-sensitive K + channel, Hslo, is a target of cGMP-dependent protein kinase phosphorylation in vivo J Biol Chem 273 32950 32956 10.1074/jbc.273.49.32950 9830046 (Pubitemid 28557688)
2. SL Archer JM Huang V Hampl DP Nelson PJ Shultz EK Weir 1994 Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase Proc Natl Acad Sci USA 91 7583 7587 10.1073/pnas.91.16.7583 7519783 (Pubitemid 24238229)
3. NF Avrova VA Tyurin Y Tyurina VE Kagan 1994 Gangliosides in postischemic cellular dysfunctions Ann N Y Acad Sci 723 353 355 10.1111/j.1749-6632.1994. tb36745.x 8030882 (Pubitemid 24228163)
4. NF Avrova IV Victorov VA Tyurin IO Zakharova TV Sokolova NA Andreeva EV Stelmaschuk YY Tyurina VS Gonchar 1998 Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes Neurochem Res 23 945 952 10.1023/A:1021076220411 9690736 (Pubitemid 28334241)
5. VM Bolotina S Najibi JJ Palacino PJ Pagano RA Cohen 1994 Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368 850 853 10.1038/368850a0 7512692 (Pubitemid 24137748)
6. V Calabrese C Mancuso M Calvani E Rizzarelli DA Butterfield AM Stella 2007 Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity Nat Rev Neurosci 8 766 775 10.1038/nrn2214 17882254 (Pubitemid 47462116)
7. L Candelise A Ciccone 2002 Gangliosides for acute ischemic stroke Stroke 33 2336 10.1161/01.STR.0000029272.13806.46 12215609 (Pubitemid 35014653)
8. R Capasso F Borrelli G Aviello F Capasso AA Izzo 2008 Inhibitory effect of the herbal antidepressant St John's wort (Hypericum perforatum) on rat gastric motility Naunyn-Schmiedeberg's Arch Pharmacol 376 407 414 10.1007/s00210-007-0230-2
9. A Carolei C Fieschi R Bruno G Toffano 1991 Monosialoganglioside GM1 in cerebral ischemia Cerebrovasc Brain Metab Rev 3 134 157 1854596
10. ZG Chen YC Lu C Zhu GJ Zhang XH Ding JY Jiang 2003 Effects of ganglioside GM1 on reduction of brain edema and amelioration of cerebral metabolism after traumatic brain injury Chin J Traumatol 6 1 23 27 12542960
11. AM Duchemin NH Neff M Hadjiconstantinou 1997 GM1 increases the content and mRNA of NGF in the brain of aged rats Neuroreport 8 3823 3827 10.1097/00001756-199712010-00032 9427377
12. AM Duchemin NH Neff M Hadjiconstantinou 1998 Induction of Trk phosphorylation in rat brain by GM1 ganglioside Ann N Y Acad Sci 845 406 10.1111/j.1749-6632.1998.tb09696.x 9668376 (Pubitemid 28365333)
13. AM Duchemin Q Ren L Mo NH Neff M Hadjiconstantinou 2002 GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain J Neurochem 81 696 707 10.1046/j.1471-4159.2002.00831.x 12065629 (Pubitemid 34809299)
14. AM Duchemin Q Ren NH Neff M Hadjiconstantinou 2008 GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors J Neurochem 104 1466 1477 10.1111/j.1471-4159.2007.05088.x 18028334 (Pubitemid 351316760)
15. DM Dudzinski T Michel 2007 Life history of eNOS: partners and pathways Cardiovasc Res 75 247 260 10.1016/j.cardiores.2007.03.023 17466957 (Pubitemid 46961923)
16. MR Fighera JS Bonini TG de Oliveira R Frussa-Filho JB Rocha CS Dutra-Filho MA Rubin CF Mello 2003 GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid Int J Biochem Cell Biol 35 465 473 10.1016/S1357-2725(02)00275-3 12565708 (Pubitemid 36140068)
17. MR Fighera JS Bonini R Frussa-Filho CS Dutra-Filho ME Hagen MA Rubin CF Mello 2004 Monosialoganglioside increases catalase activity in cerebral cortex of rats Free Radic Res 38 495 500 10.1080/1071576042000209835 15293557 (Pubitemid 38618371)
18. MR Fighera LF Royes AF Furian MS Oliveira NG Fiorenza R Frussa-Filho JC Petry RC Coelho CF Mello 2006 GM1 ganglioside prevents seizures, Na+, K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole Neurobiol Dis 22 611 623 10.1016/j.nbd.2006.01.002 16516483 (Pubitemid 43832132)
19. RF Furchgott JV Zawadzki 1980 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373 376 10.1038/288373a0 6253831 (Pubitemid 11169009)
20. AF Furian MS Oliveira LF Royes NG Fiorenza MR Fighera JC Myskiw R Weiblen MA Rubin R Frussa-Filho CF Mello 2007 GM1 ganglioside induces vasodilation and increases catalase content in the brain Free Radic Biol Med 43 924 932 10.1016/j.freeradbiomed.2007.05.035 17697937 (Pubitemid 47223634)
21. AF Furian MS Oliveira DV Magni MA Souza VT Bortoluzzi LM Bueno LF Royes CF Mello 2008 L-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain Neurochem Int 53 362 369 10.1016/j.neuint.2008.07.011 18835310
22. G Garcia-Cardena P Martasek BS Masters PM Skidd J Couet S Li MP Lisanti WC Sessa 1997 Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo J Biol Chem 272 25437 25440 10.1074/jbc.272.41.25437 9325253 (Pubitemid 27438846)
23. J Garthwaite E Southam CL Boulton EB Nielsen K Schmidt B Mayer 1995 Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one Mol Pharmacol 48 184 188 7544433
24. FH Geisler WP Coleman G Grieco D Poonian Sygen Study Group 2001 The Sygen multicenter acute spinal cord injury study Spin 26 S87 S98 10.1097/00007632- 200112151-00015
25. V Govoni E Granieri M Manconi J Capone I Casetta 2003 Is there a decrease in Guillain-Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy J Neurol Sci 216 99 103 10.1016/S0022-510X(03)00215-6 14607309 (Pubitemid 37371872)
26. WF Jackson 1998 Potassium channels and regulation of the microcirculation Microcirculation 5 85 90 10.1038/sj.mn.7300025 9789248
27. WF Jackson 2000 Ion channels and vascular tone Hypertension 35 173 178 10642294
28. WF Jackson 2005 Potassium channels in the peripheral microcirculation Microcirculation 12 113 127 10.1080/10739680590896072 15804979 (Pubitemid 40450623)
29. S Katsuki W Arnold C Mittal F Murad 1977 Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine J Cyclic Nucleotide Res 3 23 35 14978
30. T Komagamine N Yuki 2006 Ganglioside mimicry as a cause of Guillain-Barré syndrome CNS Neurol Disord Drug Targets 5 391 400 10.2174/187152706777950765 16918391
31. DH Kwak SM Kim DH Lee JS Kim SM Kim SU Lee KY Jung BB Seo YK Choo 2005 Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion Mol Cells 20 354 360 16404149
32. RW Ledeen RK Yu 1982 Gangliosides: structure, isolation, and analysis Methods Enzymol 83 139 191 10.1016/0076-6879(82)83012-7 7047999
33. MJ McGirt JR Lynch A Parra H Sheng RD Pearlstein DT Laskowitz DA Pelligrino DS Warner 2002 Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage Stroke 33 2950 2956 10.1161/01.STR.0000038986.68044.39 12468796 (Pubitemid 35462871)
34. L Mo Q Ren AM Duchemin NH Neff M Hadjiconstantinou 2005 GM1 and ERK signaling in the aged brain Brain Res 1054 125 134 10.1016/j.brainres.2005.06. 068 16084500 (Pubitemid 41219341)
35. S Moncada EA Higgs 1991 Endogenous nitric oxide: physiology, pathology and clinical relevance Eur J Clin Invest 21 361 374 10.1111/j.1365-2362.1991. tb01383.x 1718757
36. MT Nelson JM Quayle 1995 Physiological roles and properties of potassium channels in arterial smooth muscle Am J Physiol 268 C799 C822 7733230
37. RM Palmer AG Ferrige S Moncada 1987 Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 524 526 10.1038/327524a0 3495737 (Pubitemid 17085822)
38. SJ Rabin A Bachis I Mocchetti 2002 Gangliosides activate Trk receptors by inducing the release of neurotrophins J Biol Chem 277 49466 49472 10.1074/jbc.M203240200 12388556 (Pubitemid 36014382)
39. YD Rattmann S Crestani FR Lapa OG Miguel MC Marques JE da Silva-Santos AR Santos 2009 Activation of muscarinic receptors by a hydroalcoholic extract of Dicksonia sellowiana Presl. HooK (Dicksoniaceae) induces vascular relaxation and hypotension in rats Vascul Pharmacol 50 27 33 10.1016/j.vph.2008.08.005 18805508
40. V Rizzo DP McIntosh P Oh JE Schnitzer 1998 In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association J Biol Chem 273 34724 34729 10.1074/jbc.273.52.34724 9856995 (Pubitemid 29028162)
41. BE Robertson R Schubert J Hescheler MT Nelson 1993 cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells Am J Physiol 265 C299 C303 8338137
42. J Saliez C Bouzin G Rath P Ghisdal F Desjardins R Rezzani LF Rodella J Vriens B Nilius O Feron JL Balligand C Dessy 2008 Role of caveolar compartmentation in endothelium-derived hyperpolarizing factor-mediated relaxation: Ca2+ signals and gap junction function are regulated by caveolin in endothelial cells Circulation 117 1065 1074 10.1161/CIRCULATIONAHA.107.731679 18268148
43. LJ Sampson F Plane CJ Garland 2001 Involvement of cGMP and potassium channels in relaxation evoked by nitric oxide donor, diethylamine NONOate, in the rat small isolated mesenteric artery Naunyn-Schmiedeberg's Arch Pharmacol 364 220 225 10.1007/s002100100453 (Pubitemid 32802150)
44. JS Schneider 1998 GM1 ganglioside in the treatment of Parkinson's disease Ann N Y Acad Sci 845 363 373 10.1111/j.1749-6632.1998.tb09688.x 9668369 (Pubitemid 28365325)
45. JQ She M Wang DM Zhu M Tang JT Chen L Wang DY Ruan 2009 Monosialoanglioside (GM1) prevents lead-induced neurotoxicity on long-term potentiation, SOD activity, MDA levels, and intracellular calcium levels of hippocampus in rats Naunyn-Schmied Arch Pharmacol 379 517 524 10.1007/s00210-008-0379-3
46. L Svennerholm 1994 Gangliosides-a new therapeutic agent against stroke and Alzheimer's disease Life Sci 55 2125 2134 10.1016/0024-3205(94)00393-9 7997071 (Pubitemid 24372602)
47. L Svennerholm G Brane I Karlsson A Lekman I Ramstrom C Wikkelso 2002 Alzheimer disease-effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme Dement Geriatr Cogn Disord 14 128 136 10.1159/000063604 12218255
48. WK Tan CE Williams AJ Gunn EC Mallard PD Gluckman 1993 Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic-ischemic injury without causing systemic compromise Pediatr Res 34 18 22 8356012
49. K Tanaka E Dora R Urbanics JH Greenberg G Toffano M Reivich 1986 Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats Stroke 17 1170 1178 3810717
50. G Tettamanti 2004 Ganglioside/glycosphingolipid turnover: new concepts Glycoconj J 20 301 317 10.1023/B:GLYC.0000033627.02765.cc 15229395
51. CR Tirapelli SY Fukada A Yogi AZ Chignalia RC Tostes VL Lanchote FQ Cunha AM de Oliveira 2008 Gender-specific vascular effects elicited by chronic ethanol consumption in rats: a role for inducible nitric oxide synthase Brit J Pharmacol 153 468 479 10.1038/sj.bjp.0707589 (Pubitemid 351199017)
52. NG Wahlgren N Ahmed 2004 Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches Cerebrovasc Dis 17 153 166 10.1159/000074808 14694293 (Pubitemid 38032534)
53. K Yanagisawa 2007 Role of gangliosides in Alzheimer's disease Biochim Biophys Acta 1768 1943 1951 10.1016/j.bbamem.2007.01.018 17321494 (Pubitemid 47125848)
54. N Yuki 1998 Anti-ganglioside antibody and neuropathy: review of our research J Peripher Nerv Syst 3 3 18 10959233